A protein expression method
By designing a closed double-stranded DNA template, the problem of linear DNA templates being easily degraded was solved, achieving efficient protein expression and reducing costs. Furthermore, the template can be reused, simplifying the operation process.
Patent Information
- Application Number
- CN202011518448.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2020-12-21
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2040-12-21
AI Technical Summary
In existing cell-free protein expression technologies, linear DNA templates are easily degraded by exonucleases, resulting in low protein yield and high cost. Existing improved methods affect strain growth or increase operational complexity, and have not effectively solved the problem of template reuse.
A closed double-stranded DNA template is designed. By introducing complementary single-stranded DNA from both ends of the template and annealing it to form a hairpin structure, sticky ends are formed. It can be chemically modified, fixed on a solid surface, or prepared into a hydrogel to avoid exonuclease degradation.
It improves template stability and protein expression levels, reduces reaction costs, and does not require strain modification or additional protein addition. The operation is simple and the template can be reused.
Smart Images

Figure CN113801877B_ABST
Abstract
Description
Technical Field
[0001] This application relates to the field of molecular biology, and more particularly to a protein expression method. Background Technology
[0002] With the development of science and technology, cell-free protein expression technology, due to its unique open system characteristics, allows for control of reaction conditions, reactant components, and direct monitoring of reaction expression, making it a powerful protein expression method. Cell-free protein synthesis (CFPS) systems are in vitro gene expression systems that use exogenous DNA or mRNA as templates, artificially adding necessary raw materials and energy substances, and using cell extracts as conditions to synthesize proteins. This overcomes cellular limitations and allows for convenient and rapid expression of various proteins. In detail, CFPS uses DNA as a template, and under the action of RNA polymerase and transcription factors, transcribes the corresponding mRNA; then, using mRNA as a template, it translates and synthesizes proteins using ribosomes, amino acid substrates, tRNA, and energy substances within the system.
[0003] The advantage of CFPS also lies in its ability to directly use linear DNA expression templates (LETs), eliminating the need to construct the target gene into an expression vector. This significantly simplifies the CFPS workflow and shortens protein synthesis time. LET-based CFPS has become an effective tool for high-throughput production and protein screening. However, compared to plasmids, LETs are more susceptible to exonucleases in cell-free reaction environments, leading to LETs being degraded by nucleases within the reaction system and resulting in reduced protein yield.
[0004] To improve the lifespan of LETs in CFPS and the reaction yield of proteins, existing technologies employ methods such as: 1) strain modification, including gene mutation or knockout of exonuclease RecBCD, ribonuclease RNase, and polynucleotide phosphorylase; 2) addition of Gams protein that can inhibit RecBCD activity; and 3) addition of double-stranded DNA binding proteins.
[0005] However, the above methods all have drawbacks. For example, the modified strains grow more slowly, and the protein synthesis capacity of the lysates obtained from these strains is reduced, making them difficult to apply widely. Adding nuclease inhibitors has achieved better results, reducing the amount of linear template degraded per unit time and increasing protein yield. However, the added inhibitors only target one exonuclease, while other uninhibited exonucleases can still function. Furthermore, additional protein needs to be added to the system, increasing the cost and complexity of the reaction. Recently, it was reported that the protein scCro can bind to both ends of the linear template, protecting it from exonuclease degradation and significantly increasing protein expression compared to linear templates alone, but still far lower than expression using plasmid templates. This method not only requires the addition of scCro protein but also the addition of an ORC sequence to both ends of the linear template. In addition, the cost of CFPS templates is also an important factor to consider in practical applications. If the template can be reused, the overall cost of the reaction system will decrease. None of the existing solutions have addressed the template cost issue. Summary of the Invention
[0006] The purpose of this invention is to provide a DNA template for cell-free protein expression.
[0007] Another object of the present invention is to provide a method for cell-free protein expression.
[0008] According to the present invention, a DNA template for cell-free protein expression includes a reading frame for the target protein and desired 5' and 3' untranslated regions, as well as adapters on both sides, the adapters being hairpin structures formed by annealing intrastranded complementary single-stranded DNA.
[0009] According to the DNA template for cell-free protein expression of the present invention, the single strand forming the adapter contains at least one complementary base pairing region.
[0010] According to the DNA template for cell-free protein expression of the present invention, when the total number of bases in the single strand forming the adapter is odd, all bases except the middle base of the sequence are paired; when the total number of bases is even, all bases are paired.
[0011] The DNA template for cell-free protein expression according to the present invention has a base complementation region of at least 12 bp.
[0012] When the total number of bases in the connector is odd, all bases except the middle base of the sequence are paired. When the total number of bases is even, all bases are paired.
[0013] According to the present invention, a DNA template for cell-free protein expression is provided, wherein one or more bases in the adapter are attached with chemically modified groups.
[0014] According to the DNA template for cell-free protein expression of the present invention, the chemically modified group is biotin, amino, acrylamide, azide or thiol.
[0015] The DNA template for cell-free protein expression according to the present invention includes spacer sequences of appropriate length upstream and downstream of the 5' and / or 3' untranslated regions to provide adequate steric hindrance.
[0016] A method for constructing a DNA template for cell-free protein expression, the method comprising the following steps:
[0017] The reading frame and the required 5' and 3' untranslated regions for synthesizing the target protein;
[0018] Intra-stranded complementary single-stranded DNA was designed and synthesized. Hairpin structures were formed through annealing to obtain adapters. When the total number of bases in the adapter was odd, all bases except the middle base were paired. When the total number of bases in the adapter was even, all bases were paired.
[0019] The synthesized adapters were ligated to the 5' and 3' untranslated regions upstream and downstream of the protein's reading frame, respectively, to obtain DNA templates for cell-free protein expression.
[0020] According to the method of constructing a DNA template for cell-free protein expression according to the present invention, endonuclease sites of the same type as the linear template are introduced into the end-joints at the corresponding positions of the 5' and 3' ends of the single-stranded DNA, so that they can be cleaved by endonuclease to form sticky ends, which are respectively connected to the 5' and 3' ends of the target gene fragment.
[0021] According to the method for constructing a DNA template for cell-free protein expression according to the present invention, the endonuclease site selection is preferably an endonuclease that recognizes non-palindromic sequences.
[0022] According to the cell-free protein expression method of the present invention, the method includes the step of expressing the protein using the DNA template described above for cell-free protein expression.
[0023] According to the cell-free protein expression method of the present invention, the adapter of the DNA template is connected to a chemical modification group, and the DNA template is fixed on a solid surface or prepared into a hydrogel by the chemical modification group for cell-free protein expression.
[0024] According to the cell-free protein expression method of the present invention, the solid surface may be magnetic beads or other solid surfaces, preferably SA magnetic beads.
[0025] According to the cell-free protein expression method of the present invention, the DNA template is prepared into a hydrogel and then subjected to cell-free protein expression.
[0026] The above-described technical solutions adopted in the embodiments of this application can achieve the following beneficial effects:
[0027] (1) The DNA template for cell-free protein expression in this application does not have open 3' and 5' ends, and is resistant to exonuclease degradation.
[0028] (2) The external connectors at both ends can conveniently provide the template with various chemically modified bases, which greatly increases the possibility of template use. For example, the template can be fixed on the solid surface or prepared into a hydrogel, which can be reused and reduce the reaction cost of CFPS. In addition, the introduced chemical modification facilitates template enrichment, increases the local concentration of the template, and further increases the expression level of protein.
[0029] (3) The technical solution of this application does not require modification of the strain, does not affect the growth of the strain, does not require the addition of extra protein to the reaction system, is simpler to operate, and reduces costs. Attached Figure Description
[0030] The accompanying drawings, which are included to provide a further understanding of this application and form part of this application, illustrate exemplary embodiments and are used to explain this application, but do not constitute an undue limitation of this application. In the drawings:
[0031] Figure 1 A schematic diagram of the DNA template for cell-free protein expression of the present invention;
[0032] Figure 2 A schematic diagram of the method for preparing the two-end adapters of the DNA template for cell-free protein expression according to the present invention;
[0033] Figure 3 A schematic diagram showing the connection between the target gene fragment and the two end adapters via sticky ends;
[0034] Figure 4 This is a schematic diagram of the linear template with viscous ends in Example 1;
[0035] Figure 5 This is a schematic diagram comparing the structure of the ordinary linear template in Example 1 with that of the template of the present invention. The ordinary linear template is not closed at both ends, making it easily degraded by exonucleases in the reaction system and affecting the protein expression level. In contrast, the template provided by this patent is closed at both ends, which greatly improves its stability in the system. Furthermore, chemically modified bases can be introduced at the 5' or 3' linker as needed for experiments.
[0036] Figure 6This is a comparison chart of the protein expression levels of the patented template in Example 1 with those of a common linear template and a plasmid.
[0037] Figure 7 The image shows the effect of the template of the present invention against exonuclease in Example 2, wherein 1: marker, 2: ordinary linear template, 3: ordinary linear template digested with ExoIII, 4: ordinary linear template digested with RecBCD, 5: plasmid, 6: plasmid digested with ExoIII, 7: plasmid digested with RecBCD, 8: DNA template of the present invention for cell-free protein expression, 9: template of the present invention digested with ExoIII, 10: template of the present invention digested with RecBCD;
[0038] Figure 8 This is a diagram illustrating the reusability of the DNA template for cell-free protein expression according to the present invention in Example 3;
[0039] Figure 9 This is a diagram illustrating the reusability of conventional PCR products in Example 3;
[0040] Figure 10 This is a comparison chart of the expression levels of the template protein provided in Example 4 with the protein expression levels of a common linear template and plasmid;
[0041] Figure 11 This is a diagram illustrating the reuse effect of the DNA template used for cell-free protein expression in Example 5 of the present invention after preparing a hydrogel. Detailed Implementation
[0042] To make the objectives, technical solutions, and advantages of this application clearer, the technical solutions of this application will be clearly and completely described below in conjunction with specific embodiments and corresponding drawings. Obviously, the described embodiments are only a part of the embodiments of this application, and not all of them. Based on the embodiments in this application, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of this application.
[0043] The technical solutions provided by the various embodiments of this application are described in detail below with reference to the accompanying drawings.
[0044] Existing CFPS linear templates are mostly double-stranded DNA molecules with open ends, which are easily degraded by exonucleases in the reaction system, resulting in low protein expression efficiency. This invention provides a double-stranded DNA template with closed ends, namely a single-stranded circular DNA molecule.
[0045] like Figure 1As shown, according to the technical solution of the present invention, a linearly expressed DNA template is first prepared, then end adapters are prepared and connected to the linearly expressed template, thereby adding sealing adapters to both ends of the linearly expressed template.
[0046] Linear expression templates are typically obtained through gene synthesis or PCR amplification, which are standard techniques in this field. The template must contain the reading frame of the target protein and the required 5' and 3' untranslated regions. Furthermore, appropriately long spacer base sequences can be placed upstream and downstream to provide adequate steric hindrance. For ligation with the end adapters, restriction enzyme sites and protective bases are introduced at the 5' and 3' ends of the linear expression template, respectively. The restriction enzyme sites are preferably endonucleases that recognize non-palindromic sequences.
[0047] like Figure 2 As shown, to prepare the two-terminal adapters, firstly, intra-strand complementary single-stranded DNA is designed, and a hairpin structure is formed by annealing. The 5' and 3' ends of the single-stranded DNA are respectively used as the positions for introducing endonuclease sites of the same type as the linear template, so that they can be cleaved by endonuclease to form sticky ends, which are then connected to the 5' and 3' ends of the target gene fragment, respectively.
[0048] When the base sequence within the linker is designed to be inversely complementary, some bases may not be complementary. Preferably, when the total number of bases is odd, all bases except the middle base of the sequence are paired (as shown in the appendix). Figure 2 When the total number of bases is even, all bases are paired.
[0049] The adapter has endonuclease sites introduced at the corresponding positions of the 5' and 3' ends of the single-stranded DNA, so that after annealing, it contains sites that can be recognized and cleaved by selected endonucleases. After cleavage, it forms sticky ends or blunt ends, which are respectively connected to the 5' and 3' ends of the target gene fragment.
[0050] The linker sequence may contain one or more chemically modified bases; these modified bases facilitate subsequent template fixation. The chemical modification may be biotinylate, amino, acrylamide, azide, or thiol. The chemically modified bases facilitate the subsequent acquisition of different template forms.
[0051] like Figure 3 As shown, the prepared target gene fragment with sticky ends and the two end adapters are ligated using DNA ligase, resulting in a double-stranded DNA template with closed ends. During ligation, it is preferable to ligate the target gene fragment to one end of the 5' or 3' end adapter first, and then to the other end adapter, to improve ligation efficiency.
[0052] According to the cell-free protein expression method of the present invention, the method uses the above-mentioned DNA molecule as a template for protein expression.
[0053] If the prepared template contains chemically modified bases, it can be further fixed on the solid surface or a hydrogel can be prepared to further improve the template utilization rate. The chemically modified bases can be biotin-modified, amino-modified, thiol-modified, etc.
[0054] The DNA template for cell-free protein expression according to the present invention can be used directly for cell-free protein expression; it can also be immobilized on a solid surface for cell-free protein expression, wherein the solid surface can be magnetic beads or other solid surfaces, preferably SA magnetic beads; it can also be prepared into a hydrogel by itself or with other molecules for cell-free protein expression.
[0055] When using the aforementioned single-stranded circular DNA molecule as a template for protein expression in cell-free protein expression, according to the teachings of existing technology, the cell-free protein expression system includes cell extracts and a supplementary system.
[0056] The supplementary system includes: a first buffer solution or its functional equivalent, a magnesium salt or its functional equivalent, a potassium salt or its functional equivalent, an oxalate or its functional equivalent, an amino acid or a mixture of amino acids or its functional equivalent, and a mixture of nucleotides or its functional equivalent.
[0057] The first buffer solution has a molar concentration of 2–100 mM; the magnesium salt contains a molar concentration of magnesium ions of 0.5–20 mM; the potassium salt contains a molar concentration of potassium ions of 100–350 mM; or / and the oxalate has a molar concentration of 0.5–10 mM; the amino acid or amino acid mixture has a molar concentration of 0.5–3 mM; and the nucleotide mixture has a molar concentration of 0.5–1.5 mM.
[0058] For example, the first buffer is a phosphate buffer; the magnesium salt is magnesium glutamate and / or magnesium acetate; the potassium salt is potassium glutamate and / or potassium acetate; the oxalate is potassium oxalate and / or sodium oxalate; the amino acid or amino acid mixture is a mixture of at least one or more of the following twenty amino acids: glycine, alanine, valine, leucine, isoleucine, phenylalanine, proline, tryptophan, serine, tyrosine, cysteine, methionine, asparagine, glutamine, threonine, aspartic acid, glutamic acid, lysine, arginine, and histidine; the nucleotide mixture is a nucleoside triphosphate (NTP) or a nucleotide NMP, wherein the NTP includes any of the following combinations:
[0059] Adenosine triphosphate (ATP), guanosine triphosphate (GTP), uridine triphosphate (UTP), and cytidine triphosphate (CTP); or
[0060] Adenosine triphosphate (ATP) and guanosine triphosphate (GTP).
[0061] The nucleotide NMP includes any of the following combinations:
[0062] Adenine nucleotide AMP, guanine nucleotide GMP, urinary purine nucleotide UMP, and cytine nucleotide CMP; or
[0063] Adenine nucleotide AMP and guanine nucleotide GMP.
[0064] The steps for preparing the cell-free protein expression system are as follows: the template is added to the cell-free protein expression system for expression at a temperature of 15-40℃ for 0.5-24 hours.
[0065] The cell extract is selected from any one or any combination of several of the following: Escherichia coli cell extract, yeast cell extract, wheat germ extract, insect cell extract, rabbit reticulocyte extract, and CHO cell extract.
[0066] Example 1
[0067] 1. Preparation of target gene fragment:
[0068] like Figure 4 As shown, the endonuclease BssSαI, which recognizes non-palindromic sequences at both ends of the expression cassette of the target protein (green fluorescent protein), was selected on the existing pID-1 plasmid; after enzyme digestion and purification, the target gene fragment with 5' and 3' sticky ends was obtained.
[0069] 2. Preparation of 5' and 3' connectors:
[0070] like Figure 2 As shown, 5' and 3' adapters were designed, with the adapters being intra-strand reverse complementary DNA single strands. After annealing under suitable conditions, hairpin structures were formed. After purification by restriction enzyme BssSαI, the restriction enzyme used for the target gene fragment, 5' and 3' adapters with sticky ends were obtained. In order to improve template utilization, the base T at the middle position of the 5' adapter was modified with biotin-modified iBiodT.
[0071] 5' connector:
[0072] 5'-GAC CACGAG AGGATTAATCCCCCAATGATTTTTCGGAATCCCCC / iBiodT / GGGGGATTCCGAAAAATCATTGGGGGATTAATCCT CTCGTG GTC-3'
[0073] Where: iBiodT is the biotin-modified base dT; the number of bases on both sides of the symbol " / / " is the same, and the bases at both ends are completely complementary after forming a hairpin structure; the underlined symbols indicate... CACGAGand CTCGTG The recognition site that constitutes the endonuclease BssSaI;
[0074] 3' end connector:
[0075] 5'-GAC CTCGTG AGGATTAATCCCCCAATGATTTTTCGGAATCCCCC / T / GGGGGATTCCGAAAAATCATTGGGGGATTAATCCT CACGAG GTC-3'
[0076] 3. Ligate the target gene fragment to the 5' and 3' adapters.
[0077] The target gene fragment was ligated to a 3' adapter using T4 ligase and then purified. The purified product was then ligated to a 5' adapter and purified again to obtain a double-stranded DNA template with adapters added to both ends. This template is resistant to exonuclease degradation and can be directly added to a CFPS system for reaction, or it can be immobilized on a solid support surface using chemically modified adapters or prepared into a hydrogel.
[0078] 4. Cell-free protein expression
[0079] The cell-free expression system consisted of the following components (template added separately): 10 mM phosphate buffer, 1.2 mM ATP, 0.85 mM MUTP, 0.85 mM CTP, 0.85 mM GTP, 280 mM potassium glutamate, 8 mM magnesium glutamate, 2.7 mM potassium oxalate, 2 mM amino acid mixture, and 25% (v / v) E. coli extract. The prepared template was added at 7.5 ng / uL to the above system. All components were added to a PCR tube, mixed thoroughly, and placed in a ThermoMixer at 30°C and 1000 rpm for 16 hours. The expression level of the fluorescent protein was measured using a microplate reader under excitation light of 485 nm, emission light of 535 nm, and an exposure time of 0.1 s. Under the same conditions, equimolar concentrations of ordinary linear template (PCR product) and plasmid template were added separately.
[0080] The structural differences between the ordinary linear template (PCR product) and the template of the present invention prepared above are as follows: Figure 5 As shown.
[0081] like Figure 6 As shown, the protein expression level of the template provided by this invention is comparable to that of the plasmid template, which is superior to the effect of adding the double-stranded binding protein sCcro to the system reported by Zhu B et al. in 2020. Although the protein yield was increased after adding sCcro to the system, it was still far lower than the protein expression level of the plasmid template.
[0082] Example 2: Nucleic acid exonuclease digestion effect
[0083] To verify the anti-exonuclease degradation effect of the template of the present invention, various templates were treated with exonucleases ExoIII and RecBCD, respectively; in addition to the template of the present invention, controls, ordinary linear templates—PCR products (easily degraded by exonucleases) and plasmids (not easily degraded) were also added. Figure 7 As shown, the template of the present invention is the same as the plasmid. The band brightness remains unchanged before and after exonuclease treatment, and both can resist exonuclease degradation. However, after treatment with exonuclease, the target band of ordinary linear template becomes significantly weaker and diffuse bands appear, indicating that it has been severely degraded.
[0084] Example 3: Reusability of the template fixed on the magnetic bead according to the present invention
[0085] The template package obtained in the previous step is used in SA magnetic beads (MyOne) TM Streptavidin T1); template-coated magnetic beads were added to the same cell-free expression system as in Example 1, mixed thoroughly, and then placed in a ThermoMixer for shaking at 30°C and 1000 rpm for 16 hours. The expression level of the fluorescent protein was measured using a microplate reader under excitation light of 485 nm, emission light of 535 nm, and an exposure time of 0.1 s. After the first reaction, the magnetic beads were washed three times with 1×PBS solution before a second reaction, with the reaction system unchanged. A third reaction was performed in the same manner. Figure 8 As shown, the magnetic beads coated with the template of the present invention exhibit strong reusability. After being reused three times, the protein yield still decreased only slightly, which is much higher than the protein expression level using ordinary PCR products as templates.
[0086] Similar to the method described above, the magnetic beads were coated with ordinary PCR products, and the RecBCD inhibitor Gams protein was additionally added to the reaction system. After the reaction under the same conditions, as shown... Figure 9 As shown, during the second reaction, the protein yield had decreased to one-tenth of its original value. This indicates that while Gams protein can increase the yield of linear template in a short time, the linear template will still be degraded by other exonucleases in the system after a longer period. Therefore, the method of using Gams protein to protect the linear template is not as effective as the technical solution of this invention.
[0087] Example 4
[0088] 1. The preparation of the target gene fragment is as described in Example 1;
[0089] The preparation methods for the 2', 5', and 3' connectors are the same as in Example 1, only the sequence is different.
[0090] a) In adapter assembly 1, the 5' adapter and the 3' adapter each contain 12 pairs of complementary bases:
[0091] 5' connector: 5'-GAC CACGAG AGG / T / CCT CTCGTG GTC-3'
[0092] 3' connector: 5'-GAC CTCGTG AGG / T / CCTCACGAGGTC-3'
[0093] b) In linker combination 2, the 5' linker and the 3' linker each contain 12 pairs of complementary bases and several unpaired bases:
[0094] 5' connector:
[0095] 5'-GAC CACGAG AGGATTAATCCCCCA / T / TCCCCCAATGATCCT CTCGTG GTC-3'
[0096] 3' end connector:
[0097] 5'-GAC CTCGTG AGGATTAATCCCCCA / T / TCCCCCAATGATC CTCACGAG GTC-3'
[0098] 3. The ligation of the target gene fragment with the 5' and 3' linkers and subsequent cell-free protein expression are the same as in Example 1;
[0099] like Figure 10 As shown, the protein expression level of the template provided in Example 4 is much higher than that of ordinary linear templates and is comparable to that of plasmid templates.
[0100] Example 5: Preparation of DNA composite hydrogel using the template of the present invention
[0101] The template of the present invention can also be used to prepare hydrogels, thereby enriching the template, effectively increasing the local concentration of the template, further improving the expression level of the protein, and the prepared hydrogels can be reused, reducing the reaction cost of CFPS.
[0102] 1. The preparation of the target gene fragment is as described in Example 1;
[0103] 2. The preparation methods of the 5' and 3' connectors are the same as in Example 1, except that the modified bases of the two connectors are different, and templates with thiol modification at both the 5' and 3' ends are prepared.
[0104] 5' connector:
[0105] 5'-GAC CACGAGAGGATTAATCCCCCAATGATTTTTCGGAATCCCCC / HS-dT / GGGGGGATTCCGAAAAATCATTGGGGGATTAATCCT CTCGTG GTC-3'
[0106] 3' end connector:
[0107] 5'-GAC CTCGTG AGGATTAATCCCCCAATGATTTTTCGGAATCCCCC / HS-dT / GGGGGGATTCCGAAAAATCATTGGGGGATTAATCCT CACGAG GTC-3'
[0108] 3. Preparation of DNA composite hydrogels
[0109] (1) Preparation of solution 1: Dissolve clay in pure water to prepare a clay solution with a mass fraction of 4%;
[0110] (2) Preparation of solution 2: Add four-arm polyethylene glycol thiol (number average molecular weight of 20,000) to the above solution 1 and mix evenly, wherein the mass fraction of the four-arm polyethylene glycol thiol is 4%;
[0111] (3) Preparation of solution 3: Dissolve four-arm polyethylene glycol acrylate (number average molecular weight of 20,000) in 2x PBS (pH=7) to prepare a 4% (w / w) four-arm polyethylene glycol acrylate solution.
[0112] (4) Preparation of solution 4: Add the prepared thiol-modified template to the above solution 3 and mix well, wherein the final concentration of the template is 200 ng / μL;
[0113] (5) Take 5 μL of each of the above solutions 2 and 4, mix them evenly at 4℃, and then react at 37℃ for 2 h to obtain DNA composite hydrogel.
[0114] 4. Cell-free protein expression
[0115] The DNA composite hydrogel prepared with the thiol-modified template was added to the same cell-free expression system as in Example 1, with a final template concentration of 20 ng / μL. After homogenization, the mixture was placed in a ThermoMixer and shaken at 30°C and 1000 rpm for 16 hours. The expression level of fluorescent protein was measured using a microplate reader under excitation light of 485 nm, emission light of 535 nm, and an exposure time of 0.1 s. After the first reaction, the magnetic beads were washed three times with 1×PBS solution before a second reaction, with fresh reaction solution added, keeping the reaction system unchanged. A third reaction was performed in the same manner. Figure 11 As shown, the hydrogel prepared from the template of this application exhibits strong reusability. After being reused three times, the protein yield did not decrease and was much higher than the protein expression level using ordinary PCR products as templates.
[0116] The above description is merely an embodiment of this application and is not intended to limit the scope of this application. Various modifications and variations can be made to this application by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of this application should be included within the scope of the claims of this application. sequence list <110> Suzhou Perotine Biotechnology Co., Ltd. <120> A protein expression method <160> 6 <170> SIPOSequenceListing 1.0 <210> 1 <211> 88 <212> DNA <213> Artificial Sequence <400> 1 gaccacgaga ggattaatcc cccaatgatt tttcggaatc ccccggggga ttccgaaaaa 60 tcattggggg attaatcctc tcgtggtc 88 <210> 2 <211> 89 <212> DNA <213> Artificial Sequence <400> 2 gacctcgtga ggattaatcc cccaatgatt tttcggaatc cccctggggg attccgaaaa 60 atcattgggg gattaatcct cacgaggtc 89 <210> 3 <211> 25 <212> DNA <213> Artificial Sequence <400> 3 gaccacgaga ggtcctctcg tggtc 25 <210> 4 <211> 25 <212> DNA <213> Artificial Sequence <400> 4 gacctcgtga ggtcctcacg aggtc 25 <210> 5 <211> 49 <212> DNA <213> Artificial Sequence <400> 5 gaccacgaga ggattaatcc cccattcccc caatgatcct ctcgtggtc 49 <210> 6 <211> 49 <212> DNA <213> Artificial Sequence <400> 6 gacctcgtga ggattaatcc cccattcccc caatgatcct cacgaggtc 49
Claims
1. A method for cell-free protein expression, characterized in that, The method is applied to one-pot cell-free protein expression, including the step of adding a DNA template to a cell-free protein expression system for expression, wherein... The expression temperature is 15-40℃, and the time is 0.5-24h; The DNA template was constructed through the following steps: Preparation of linear expression template: Synthesize the reading frame of the target protein and the 5' and 3' untranslated regions upstream and downstream of the reading frame, and introduce restriction enzyme sites at the 5' and 3' ends, respectively; Synthesize intrastranded complementary single-stranded DNA, anneal to form hairpin structures, and obtain adapters. In this process, endonuclease sites of the same type as the reading frame of the target protein and its upstream and downstream 5' and 3' untranslated regions are introduced at the 5' and 3' ends of the single-stranded DNA, so that it can be cleaved by endonuclease to form sticky ends, which are then attached to the 5' and 3' ends of the target gene fragment, respectively. The synthesized adapters were ligated to the 5' and 3' untranslated regions upstream and downstream of the target protein reading frame, respectively, resulting in a double-stranded DNA template with closed ends. The adapter is connected to a chemically modified group, and the DNA template is fixed on a solid surface by the chemically modified group for cell-free protein expression; wherein, the solid surface is a magnetic bead surface, and the chemically modified group is biotin, amino, acrylamide, azide, or thiol; the DNA template fixed on the solid phase can be repeatedly used for cell-free protein expression. Alternatively, the prepared DNA template can be made into a hydrogel for cell-free protein expression; The single-stranded DNA forming the adapter contains at least one complementary base pairing region. When the total number of bases in the single-stranded DNA forming the adapter is odd, all bases except the middle base of the sequence are paired; when the total number of bases is even, all bases are paired. The number of bases in the complementary base pairing region is at least 12 bp.
2. The cell-free protein expression method according to claim 1, characterized in that, The endonuclease site is the recognition site of an endonuclease that recognizes a non-palindromic sequence.
Citation Information
Patent Citations
DNA hydrogel, and preparation method and application thereof
CN111040198A
Cell-Free Protein Synthesis
US20080153128A1
Closed linear DNA production
CN109844134A
Enhanced in vitro protein synthesis
US20030166054A1
Method for protein expression starting from stabilized linear short DNA in cell-free in vitro transcription / translation systems with exonuclease-containing lysates or in a cellular system containing exonucleases
US20040259081A1
